Alzheimer's Disease Archives

Brain maps to assist disease diagnosis, brain surgery

Researchers from the Howard Florey Institute in Melbourne are developing new technology to create individualised brain maps that will revolutionise diagnosis of disease and enhance the accuracy of brain surgery. – Researchers from the Howard Florey Institute in Melbourne are developing new technology to create individualised brain maps that will revolutionise diagnosis of disease like multiple sclerosis, Parkinson’s disease, Alzheimer’s disease and Huntington’s disease, and enhance the accuracy of brain surgery.

Bapineuzumab promising in treating Alzheimer’s disease

Elan and Wyeth have released results of a phase 2 study of bapineuzumab, an attempt at treating Alzheimer’s disease. – Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) announced encouraging preliminary findings from a Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease. In the 18-month trial, bapineuzumab appeared to have clinical activity in treating Alzheimer’s disease.

Novel approach to treat Alzheimer’s disease

JADO Technologies GmbH announced the publication of a paper in Science demonstrating a potential novel strategy for therapeutic intervention in Alzheimer?s disease. – JADO Technologies GmbH, the leading developer of RAFT intervention therapeutics, announced the publication of a paper in Science demonstrating a potential novel strategy for therapeutic intervention in Alzheimer’s and other diseases by targeting discrete sub-compartments in the cell membrane (RAFTS).

Obesity in midlife increases dementia risk

Kaiser Permanente Study Shows That a Larger Abdomen in Midlife Increases Risk of Dementia; Overweight and obese individuals with large bellies have double or triple the risk of dementia – People in their 40s with larger stomachs have a higher risk for dementia when they reach their 70s, according to a study published in the March 26, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.

$1 million help to find Alzheimer’s disease cure

UK’s best-selling author, Terry Pratchett, has pledged $1million to leading UK charity, the Alzheimer?s Research Trust, in a bid to help find a cure for the devastating disease – Alzheimer’s disease. – UK’s best-selling author, Terry Pratchett, has pledged $1million to leading UK charity, the Alzheimer’s Research Trust, in a bid to help find a cure for the devastating disease, with which he was diagnosed in December 2007.

Diesel exhaust inhalation stresses your brain

A short exposure to the diesel fumes can affect your brain. The study reveals that an hour of sniffing exhaust induces a stress response in the brain’s activity. – If the smell of diesel exhaust isn’t enough to make you avoid getting a lungful, new research now shows that even a short exposure to the fumes can affect your brain. The study reveals that an hour of sniffing exhaust induces a stress response in the brain’s activity.

Does ginkgo biloba affect memory?

People who reliably took the ginkgo biloba supplement had a 68 percent lower risk of developing mild memory problems. – Taking the supplement ginkgo biloba had no clear-cut benefit on the risk of developing memory problems, according to a study published in the February 27, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.

Improved cognitive health among older Americans

Rates of cognitive impairment among older Americans are on the decline, according to a new study supported by the National Institutes of Health (NIH) comparing the cognitive health of older people in 1993 and 2002. Higher levels of education were associated with better cognitive health. – Higher levels of health education improved cognitive health among older Americans. Rates of cognitive impairment among older Americans are on the decline, according to a new study supported by the National Institutes of Health (NIH) comparing the cognitive health of older people in 1993 and 2002.

Memory loss, less common in older Americans

Good news on gray matter: Memory loss and other cognitive impairment becoming less common in older Americans, U-M study finds; Better education, finances & cardiovascular care may be boosting brain health. – It appears that memory loss and thinking problems are becoming less common among older Americans. A new study shows a downward trend in the rate of “cognitive impairment” – the umbrella term for everything from significant memory loss to dementia and Alzheimer’s disease – among people aged 70 and older.

Vitamin B12, folate deficiency raises dementia risk

Changes in folate, vitamin B12 and homocysteine associated with incident dementia. – Folate deficiency is associated with a tripling in the risk of developing dementia among elderly people, suggests research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry.

Lhx2 creator gene for brain tissue repair

UCI study identifies the specific role for gene linked to cortical development, cerebral cortex points to potential stem cell treatments. – University of California, Irvine researchers have identified a gene that is specifically responsible for generating the cerebral cortex, a finding that could lead to stem cell therapies to treat brain injuries and diseases such as stroke and Alzheimer’s.

Statins, cholesterol lowering drugs may not prevent Alzheimer’s Disease

A large US study suggests that statin, cholesterol lowering drug use does not lower the risk of Alzheimer’s disease (AD). – Taking statins, which are cholesterol-lowering drugs, offers no protection against Alzheimer’s disease, revealed by US researchers at Rush University Medical Center in Chicago.